4:36 PM
 | 
Jul 12, 2013
 |  BC Extra  |  Company News

FDA cancels MoxDuo advisory committee meeting

As expected, FDA canceled a July 17 meeting of the Anesthetic and Analgesic Drug Products Advisory Committee to discuss an NDA for MoxDuo IR morphine/oxycodone from QRxPharma Ltd. (ASX:QRX;...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >